Purchase Order 75F40122P00054
Award Date 3/17/22
Potential Completion Date 9/6/22
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Phoenixbio Co., LTD., a Japan-based for-profit organization that provides contract research services utilizing PXB mice, a humanized liver mouse model. The $16,500.00 contract supports biomedical research efforts and provides products such as human...
- The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
- The Department of Health and Human Services Food and Drug Administration awarded a $47,945 purchase order to Discovery Life Sciences, LLC for human primary hepatocytes, recovery, plating, and induction media. This firm fixed price contract supports the FDA's research and development efforts through the delivery of human liver cells and associated media. Discovery Life Sciences will perform the work in Huntsville, Alabama under the total small business set aside designation. No major...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of human induced pluripotent stem cell-derived cells. The $26,680 contract is to provide specialized cell cultures, including cardiomyocytes, neurons, astrocytes, and hepatocytes, to support the FDA's active research program. The award has no set-aside designation and is a sole-source award,...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Discovery Life Sciences, LLC, a small disadvantaged business, on August 2, 2022. The contract has a ceiling value of $48,945.00 and a completion date of November 1, 2022. The contract is for the procurement of primary human hepatocytes and media, as requested in the FDA's Sources Sought Notice FDA-SSN-1252684. Discovery Life Sciences has over a decade of experience supporting federal agencies'...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, has been awarded a $48.9K firm fixed-price purchase order by the Food and Drug Administration (FDA) for cryopreserved human hepatocytes, with a completion date of September 24, 2026. The contract, awarded on September 19, 2025, with no set-aside designation, will be performed at the vendor's location in Grand Island, NY. Life Technologies Corporation is a leading supplier...
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $24,948 purchase order to Phoenixbio Co., LTD. of Japan. The firm fixed price contract is for the delivery of 18 plates of 24-well plates containing PXBCELLS to support NIDDK research efforts. The one year contract runs from September 2, 2023 through September 1, 2024 and will be performed in...
- The U.S. Food and Drug Administration (FDA), through its National Center for Toxicological Research (NCTR), awarded a $24,895.00 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. for the supply of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs), also referred to as "iCell Macrophages" from lot #106775. This sole-source procurement was conducted under the authority of FAR 13.106-1(b)(1) to support an approved scientific study (S00913) focused...